Millennium Management
IMNM icon

Millennium Management’s Immunome IMNM Stock Holding History

Millennium Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Buy
130,367
+111,571
+594% +$2.48M ﹤0.01% 3517
2025
Q4 		$404K Sell
18,796
-23,088
-55% -$405K ﹤0.01% 5079
2025
Q3 		$490K Sell
41,884
-71,668
-63% -$713K ﹤0.01% 5084
2025
Q2 		$1.06M Sell
113,552
-347,507
-75% -$2.85M ﹤0.01% 4363
2025
Q1 		$3.1M Buy
461,059
+302,631
+191% +$2.9M ﹤0.01% 3348
2024
Q4 		$1.68M Buy
+158,428
New +$1.91M ﹤0.01% 3780
2024
Q2 		– Sell
-465,286
Closed -$11.5M – 6198
2024
Q1 		$11.5M Buy
465,286
+429,268
+1,192% +$8.71M ﹤0.01% 2055
2023
Q4 		$385K Buy
36,018
+6,927
+24% +$57.6K ﹤0.01% 4809
2023
Q3 		$243K Sell
29,091
-36,915
-56% -$271K ﹤0.01% 5025
2023
Q2 		$522K Sell
66,006
-83,644
-56% -$457K ﹤0.01% 4507
2023
Q1 		$747K Buy
+149,650
New +$732K ﹤0.01% 4333
2021
Q4 		– Sell
-21,089
Closed -$514K – 7074
2021
Q3 		$514K Sell
21,089
-15,581
-42% -$272K ﹤0.01% 5324
2021
Q2 		$634K Buy
+36,670
New +$810K ﹤0.01% 5095
2021
Q1 		– Sell
-67,863
Closed -$657K – 6199
2020
Q4 		$657K Buy
+67,863
New +$792K ﹤0.01% 4006

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Millennium Management's IMNM Position: Q1 2026 in Review

Millennium Management increased its Immunome (IMNM) stake by 594% in Q1 2026, buying an estimated $2.48M and bringing the position to 130,367 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3517.

Millennium Management first reported a position in IMNM in Q4 2020 and has held it in 14 quarters since. The position peaked at $11.5M in Q1 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Millennium Management held 130,367 shares of Immunome worth $2.85M as of Q1 2026.
  • Millennium Management bought 111,571 Immunome shares in Q1 2026, an estimated $2.48M.
  • Immunome made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3517 holding.
  • Millennium Management first reported a position in Immunome in Q4 2020 and has held it in 14 quarters since.
  • Millennium Management's Immunome position peaked at $11.5M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.